The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements

Molecular and Cellular Endocrinology

Volumn 157, Issue 1-2, 1999, Pages 105-119

  Klinge, Carolyn M ^a   Bowers, Jennifer L ^a   Kulakosky, Peter C ^a   Kamboj, Kulwant Kaur ^a   Swanson, Hollie I ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aryl hydrocarbon receptor; Dioxin; Estrogen receptor; Estrogen response element; Xenobiotic response element

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; LIGAND; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR AFFINITY; REPORTER GENE;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASE SEQUENCE; BENZO(A)PYRENE; BINDING, COMPETITIVE; CATTLE; CONSENSUS SEQUENCE; CYTOCHROME P-450 CYP1A1; DIMERIZATION; DNA-BINDING PROTEINS; DRUG INTERACTIONS; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GENE EXPRESSION; GENES, REPORTER; HUMANS; OLIGONUCLEOTIDES; POLYCHLORINATED BIPHENYLS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TETRACHLORODIBENZODIOXIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; XENOBIOTICS;

EID: 0032745979     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00165-3     Document Type: Article

References (70)

1. Abbondanza C., deFalco A., Nigro V., Medici N., Armetta I., Molinari A.M., Moncharmont B., Puca G.A. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor. Steroids. 58:1993;4-12.
2. Anolik J.H., Klinge C.M., Hilf R., Bambara R.A. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry. 34:1995;2511-2520.
3. Beato M., Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocrine Rev. 17:1996;587-609.
4. Bentley D.L., Groudine M. Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol. Cell. Biol. 6:1986;3481-3489.
5. Berry M., Nunez A.M., Chambon P. Estrogen responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. U.S.A. 86:1989;1218-1222.
6. Biegel L., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 37:1990;725-732.
7. Birnbaum L.S., DeVito M.J. Use of toxic equivalency factors for risk assessment for dioxins and related compounds. Toxicology. 105:1995;391-401.
8. Brown A.M., Jeltsch J.M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. U.S.A. 81:1984;6344-6348.
9. Castro-Rivera E., Safe S. Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. J. Steroid Biochem. Mol. Biol. 64:1998;287-295.
10. Chaloupka K., Krishnan V., Safe S. Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells: role of the Ah receptor. Carcinogenesis. 13:1992;2233-2239.
11. Chan W.K., Chu R., Jain S., Reddy J.K., Bradfield C.A. Baculovirus expression of the Ah receptor and Ah receptor nuclear translocater. Evidence for additional dioxin responsive element-binding species and factors required for signaling. J. Biol. Chem. 269:1994;26464-26471.
12. Dong A., Huang C., Brown R.E., Ma W.-Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem. 272:1997;9962-9970.
13. Driscoll M.D., Sathya G., Muyan M., Klinge C.M., Hilf R., Bambara R.A. Sequence requirements for estrogen receptor binding to estrogen response elements. J. Biol. Chem. 273:1998;29321-29330.
14. Duan R., Porter W., Safe S. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer Cells: role of estrogen receptor Sp1 complex formation. Endocrinology. 139:1998;1981-1990.
15. Fenton C., El-Gawely M.R. Pyrophosphate in the binding reaction increases the sensitivity of mobility shift analysis. Biotechniques. 23:1997;248-250.
16. Foekens J.A., Rio M.C., Seguin P., van Putten W.L., Fauque J., Nap M., Klijn J.G., Chambon P. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res. 50:1990;3832-3837.
17. Fritsch M., Welch R.D., Murdoch F.E., Anderson I., Gorski J. DNA allosterically modulates the steroid binding domain of the estrogen receptor. J. Biol. Chem. 267:1992;1823-1828.
18. Gillesby B.E., Stanostefano M., Porter W., Safe S., Wu Z.F., Zacharewski T.R. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry. 36:1997;6080-6089.
19. Gray W.G., Gorski J. Identification and characterization of an estrogen-responsive element binding protein repressed by estradiol. Biochemistry. 35:1996;11685-11692.
20. Hoivik D., Willett K., Wilson C., Safe S. Estrogen does not inhibit 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 Cells. J. Biol. Chem. 272:1997;30270-30274.
21. Holcomb H., Safe S. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 82:1994;43-47.
22. Johnson S.D., Liu X., Zuo F., Eisenbraun T.L., Wiley S.R., Kraus R.J., Mertz J.E. Estrogen-related receptorα1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol. Endocrinol. 11:1997;342-352.
23. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
24. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1990;1603-1614.
25. Katzenellenbogen B.S., Korach K.S. Editorial: a new actor in the estrogen receptor drama-enter ERβ Endocrinology. 138:1997;861-862.
26. Kharat I., Saatcioglu F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem. 271:1996;10533-10537.
27. Klinge C.M., Peale F.V. Jr, Hilf R., Bambara R.A., Zain S. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res. 52:1992;1073-1081.
28. Klinge C.M., Traish A.M., Bambara R.A., Hilf R. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor when the receptor binds estrogen response element DNA. J. Steroid Biochem. Mol. Biol. 57:1996;51-66.
29. Klinge C.M., Silver B.F., Driscoll M.D., Sathya G., Bambara R.A., Hilf R. COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression. J. Biol. Chem. 272:1997;31465-31474.
30. Klinge C.M., Studinski-Jones A.L., Kulakosky P.C., Bambara R.A., Hilf R. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Mol. Cell. Endocrinol. 143:1998;79-90.
31. Kraus W.L., Montano M.M., Katzenellenbogen B.S. Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol. Endocrinol. 8:1994;952-969.
32. Kress S., Greenlee W.F. Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57:1997;1264-1269.
33. Krishnan A.V., Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol. Appl. Pharmacol. 120:1993;55-61.
34. Krishnan A.V., Safe S. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15:1995;6710-6719.
35. Kuil C.W., Brouwer A., van der Saag P.T., van der Burg B. Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms. J. Biol. Chem. 273:1998;8829-8834.
36. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
37. Kuiper G.G., Carlsson B., Grandien J., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
38. Kuiper G.G., Lemmen J.G., Carlsson B., Conton J.C., Safe S.H., van der Saag P., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4563.
39. Kuiper G.G., Shughrue P.J., Merchenthaler I., Gustafsson J.A. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front. Neuroendocrinol. 19:1998;253-286.
40. Lefebvre O., Wolf C., Kedinger M., Chenard M.P., Tomasetto C., Chambon P., Rio M.C. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J. Cell. Biol. 122:1993;191-198.
41. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., Rio M.C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 274:1996;259-262.
42. Li X., Johnson D.C., Rozman K.K. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on estrous cyclicity and ovulation in female Sprague-Dawley rats. Toxicol. Lett. 78:1995;219-222.
43. Li X., Johnson D.C., Rozman K.K. Reproductive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female rats: ovulation, hormonal regulation, and possible mechanism(s). Toxicol. Appl. Pharmacol. 133:1995;321-327.
44. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
45. Mohamood A.S., Gyles P., Balan K.V., Hollis V.W., Eckberg W.R., Asseffa A., Han Z., Wyche J.H., Anderson W.A. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines. J. Submicrosc. Cytol. Pathol. 29:1997;1-17.
46. Nardulli A.M., Romine L., Carpo C., Greene G.L., Rainish B. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol. Endocrinol. 10:1996;694-704.
47. Nass S.J., Dickson R.B. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res. Treat. 44:1997;1-22.
48. Nesaretnam K., Corcoran D., Dils R.R., Darbe P. 3,4,3′,4′-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. Mol. Endocrinol. 10:1996;923-936.
49. Nguyen H.N., Sevin B.U., Averette H.E., Voigt W., Perras J., Angioli R., Ramos R., Donato D., Penalver M. Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry. Gynecol. Oncol. 46:1992;55-61.
50. Pavlik E.J., Coulson P.B. Hydroxylapatite 'batch' assay for estrogen receptor: increased sensitivity over present receptor assays. J. Steroid Biochem. 7:1976;357-368.
51. Peale F.V. Jr, Ishibe Y., Klinge C.M., Zain S., Hilf R., Bambara R.A. Rapid purification of the estrogen receptor by sequence-specific DNA affinity chromatography. Biochemistry. 28:1989;8671-8675.
52. Postlind H., Vu T.P., Tukey R.H., Quattrochi L.C. Response of human CYP1-luciferase plasmids to 2,3,7,8- tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 118:1993;255-262.
53. Ricci M.S., Toscano D.G., Mattingly C.J., Toscano W.A.J. Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J. Biol. Chem. 274:1999;3430-3438.
54. Romkes M., Piskorska-Pliszynska J., Safe S. Effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol. Appl. Pharmacol. 87:1978;306-314.
55. Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ. Health Persp. 100:1993;259-268.
56. Safe S., Krishnan V. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch. Toxicol. Suppl. 17:1995;99-115.
57. Safe S., Astroff B., Harris M., Zacharewski T., Dickerson R., Romkes M., Biegel L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action. Pharmacol. Toxicol. 69:1991;400-409.
58. Sun G., Safe S. Antiestrogenic activities of alternate-substituted polychlorinated dibenzofurans in MCF-7 human breast cancer cells. Cancer Chemother. Pharmacol. 40:1997;239-244.
59. Swanson H.I., Bradfield C.A. The AH-receptor: genetics, structure and function. Pharmacogenetics. 3:1993;213-230.
60. Swanson H.I., Chan W.K., Bradfield C.A. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem. 270:1995;26292-26302.
61. Thomsen J.S., Wang X., Hines R.N., Safe S. Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis. 15:1994;933-937.
62. Tian Y., Ke S., Thomas T., Meeker R.J., Gallo M.A. Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Steroid Biochem. Mol. Biol. 67:1998;17-24.
63. Tian Y., Ke S., Thomas T., Meeker R.J., Gallo M.A. Regulation of estrogen receptor mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin as measured by competitive RT-PCR. J. Biochem. Mol. Toxicol. 12:1998;71-77.
64. Tsai M.-J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-483.
65. van der Burg B., deGroot R.P., Isbrucker L., Kruijer W., deLaat S.W. Stimulation of TPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells. Mol. Endocrinol. 4:1990;1720-1726.
66. Watson P.H., Pon R.T., Shiu R.P.C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51:1991;3996-4000.
67. Weisz A., Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol. 2:1988;816-824.
68. Weisz A., Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucl. Acids Res. 18:1990;5097-5106.
69. White T.E.K., Gasiewicz T.A. The human estrogen receptor structural gene contains a DNA sequence that binds activated mouse and human Ah receptors. Biochem. Biophys. Res. Commun. 193:1993;956-962.
70. Zacharewski T.R., Bondy K.L., McDonell P., Wu Z.F. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Cancer Res. 54:1994;2707-2713.